NEWARK – The Attorney General is proposing new rules concerning limitations on and obligations associated with the acceptance of compensation from pharmaceutical manufacturers. The public may submit written comments to this proposal through December 1, 2017.
The proposed rules establish principled standards to minimize the potential for conflicts of interest between prescribers and pharmaceutical manufacturers to ensure that patient care is guided by the unbiased, best judgment of the treating prescriber.
The proposed rules strengthen and clarify existing limitations for licensees of the Boards of Medical Examiners, Dentistry and Optometry, and extends those standards to Advanced Practice Nurses, the only Board of Nursing licensees with prescribing authority.
In connection with this notice of proposal, the Attorney General will hold a public hearing to take testimony from interested parties to gather facts to inform the proposed rulemaking and to afford ample opportunity for the receipt of public comment from the regulated communities, industry representatives, and the public at large.
The public hearing will be held on Thursday, October 19, 2017. Requests to speak must be submitted in writing no later than October 10, 2017.
The proposed regulations, and information on how to submit a request to speak or to submit a comment, can be viewed here.
Follow the Division of Consumer Affairs on its website.
Follow the New Jersey Attorney General’s Office online at Twitter, Facebook, Instagram & YouTube. The social media links provided are for reference only. The New Jersey Attorney General’s Office does not endorse any non-governmental websites, companies or applications.